Zoetis Inc - Class A

Research Zoetis Inc - Class A (ZTS) on Bullrun: valuation model: 34.8% undervalued, market cap USD 30.71B, P/E 12.1, dividend yield 2.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerZTS
ExchangeNYSE
CountryUnited States
SectorHealthcare
IndustryDrug Manufacturers-Specialty & Generic
CurrencyUSD
Valuation signal34.8% undervalued
Market capUSD 30.71B
P/E12.1
Dividend yield2.8%
Financial periodFY2025
RevenueUSD 9.47B
Revenue growth2.3%
Net incomeUSD 2.67B
Free cash flowUSD 2.28B
Gross margin71.8%

Valuation Snapshot

Bullrun's latest valuation model marks Zoetis Inc - Class A as 34.8% undervalued; latest market cap is USD 30.71B; P/E is 12.1; dividend yield is 2.8%.

About Zoetis Inc - Class A

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep.

Frequently asked questions

Is Zoetis Inc - Class A overvalued or undervalued?

Bullrun's valuation model currently marks Zoetis Inc - Class A as 34.8% undervalued.

What is Zoetis Inc - Class A's market cap?

Zoetis Inc - Class A's market capitalization is USD 30.71B.

What is Zoetis Inc - Class A's P/E ratio?

Zoetis Inc - Class A's price-to-earnings (P/E) ratio is 12.1.

Does Zoetis Inc - Class A pay a dividend?

Zoetis Inc - Class A has a dividend yield of 2.8%.